Krystal Historical Valuation

KRYS Stock  USD 194.56  4.16  2.18%   
Some fundamental drivers such as market cap or Krystal Biotech enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Krystal Biotech valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Krystal Biotech's future value.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krystal Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Krystal Stock please use our How to Invest in Krystal Biotech guide.

About Krystal Valuation Data Analysis

Valuation is the financial process of determining what Krystal Biotech is worth. Krystal Biotech valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Krystal Biotech valuation ratios help investors to determine whether Krystal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krystal with respect to the benefits of owning Krystal Biotech security.

Krystal Biotech Valuation Data Chart

Market Cap is likely to gain to about 3.5 B in 2024. Enterprise Value is likely to gain to about 3.2 B in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as Krystal Biotech theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Krystal Biotech debt, but would also pocket its cash. Enterprise Value is more accurate representation of Krystal Biotech value than its market capitalization because it takes into account all of Krystal Biotech existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Krystal Stock Analysis

When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.